| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |